Oleg Nodelman
PersonHeard in 1 episode across 1 show since Jun 2026
Oleg Nodelman is an investor who appeared as a guest on the 'All-In with Chamath, Jason, Sacks & Friedberg' podcast. He participated in the 'All-In's Best Ideas Pitch Competition' episode, presenting top investment trades live.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 1 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
What Oleg Nodelman has said on podcasts
8 statements
Actis’s mini-protein platform can carry any radioactive payload
“A platform that can carry any radioactive payload”
Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades LiveListen at 31:52
- on Actis Oncology clinical programsNeutralJun 12, 2026· All-In with Chamath, Jason, Sacks & Friedberg
Actis expects initial data from its Nectin4 and B7H3 programs in 2027
“publicly guided to initial clinical data in both of these lead programs in 2027”
Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades LiveListen at 32:38
Radiopharmaceuticals have a competitive moat because China cannot access radioisotopes
“because the class involves radioisotopes, it's off limits to China”
Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades LiveListen at 33:33
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Oleg Nodelman, newest first
